Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting

被引：2
|
作者：
Robidoux, A. [1 ]
McCullough, D. [2 ]
Lau, A. [2 ]
Stoppler, M. [2 ]
Chao, C. [2 ]
机构：
[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Genom Hlth Inc, Redwood City, CA USA
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30262-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P171
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] Is the 21-Gene Breast Cancer Test (Oncotype DX®) Cost-Effective?
    Pronzato, P.
    Plun-Favreau, J.
    CANCER RESEARCH, 2011, 71
  • [32] The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients - the final analysis of the Polish real-life survey PONDx
    Jarzab, Michal
    Litwiniuk, Maria
    Innis, Paige
    Lacko, Aleksandra
    Enderle, Gesine
    Czartoryska-Arlukowicz, Bogumila
    Talerczyk, Malgorzata
    Streb, Joanna
    Wysocki, Piotr
    Suchodolska, Grazyna
    Szymanowski, Bartosz
    Duchnowska, Renata
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2024, 28 (03): : 245 - 252
  • [33] Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer
    Rutter, Charles E.
    Yao, Xiaopan
    Mancini, Brandon R.
    Aminawung, Jenerius A.
    Chagpar, Anees B.
    Saglam, Ozlen
    Hofstatter, Erin W.
    Abu-Khalaf, Maysa
    Gross, Cary P.
    Evans, Suzanne B.
    CLINICAL BREAST CANCER, 2016, 16 (01) : 59 - 62
  • [34] Identifying anatomopathological factors associated with a Oncotype DX 21-gene recurrence score higher than 25 in menopaused women
    Guerif, Clara
    Jamelot, Mathieu
    Kebir, Fatima
    Zilberman, Sonia
    Seknazi, Lauren
    Barthere, Xavier
    De Forceville, Louise
    Theodore, Claire
    Touboul, Cyril
    Buob, David
    Gligorov, Joseph
    Benderra, Marc Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Metabolic syndrome and breast cancer recurrence within the 21-gene recurrence score assay.
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, Norah Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [36] Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, N. Lynn
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 597 - 603
  • [37] Oncotype DX® recurrence score as a predictor of response to neoadjuvant chemotherapy
    Riba, Luis
    Gruner, Ryan
    Tung, Nadine
    James, Ted
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 264 - 264
  • [38] Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
    Jeanette Muniz
    Kelley M. Kidwell
    N. Lynn Henry
    Breast Cancer Research and Treatment, 2016, 157 : 597 - 603
  • [39] The 21-Gene Recurrence Score in Male Breast Cancer
    Gulisa Turashvili
    Monica Gonzalez-Loperena
    Edi Brogi
    Maura Dickler
    Larry Norton
    Monica Morrow
    Hannah Y. Wen
    Annals of Surgical Oncology, 2018, 25 : 1530 - 1535
  • [40] The Oncotype DX® assay use in breast cancer in an Australian institutional setting
    Choi, J. D. W.
    Hughes, T. M. D.
    Marx, G.
    Boyages, J.
    Rutovitz, J.
    Hasovits, C.
    Parasyn, A.
    Edirimanne, S.
    Ngui, N. K.
    BREAST, 2021, 56 : S66 - S67
12345